Last checked at 29 Jul 2021 08:07
AstraZeneca lifts EPS guidance as H1 revenues jump
(Sharecast News) - AstraZeneca posted a jump in first-half revenue on Thursday as it updated its guidance to include recently-acquired Alexion Pharmaceuticals.
Read more
- Home
- Share Prices
- AQSE Share Prices
- Euronext
- Stock Screeners
- Share Chat
- FX
- News & RNS
- Events
- Media
- Trading Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News1
AZN Share
Chat
AZN Share
Trades
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
Astrazeneca Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
11,352.00
Bid:
10,750.00
Ask:
11,500.00
Change:
0.00 (0.00%)
Spread:
750.00 (6.977%)
Open:
0.00
High:
0.00
Low:
0.00
Prev. Close:
11,352.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.29 Jul 2021 07:51
UPDATE 3-AstraZeneca COVID-19 sales jump as drugmaker navigates vaccine challenges
* Sales of $1.17 bln in H1 from COVID-19 vaccine* Q2 earnings miss forecasts, sales beat* Now expects FY sales to grow by low-twenties percentage (Writes through with details)By Pushkala Aripaka and Alistair SmoutJuly 29 (Reuters) - Second-quarter s...
Read more29 Jul 2021 07:51
UPDATE 2-AstraZeneca COVID-19 vaccine sales jump, but U.S. plans delayed
* Sales of $1.17 bln in H1 from COVID-19 vaccine* Q2 earnings miss forecasts, sales beat* Now expects FY sales to grow by low-twenties percentage (Writes through with detail)By Pushkala Aripaka and Alistair SmoutJuly 29 (Reuters) - Second-quarter sa...
Read more29 Jul 2021 07:51
UPDATE 1-AstraZeneca vaccine sales jump to $894 mln, submission for U.S. approval delayed
(Adds detail)July 29 (Reuters) - AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months, and the drugmaker updated its 2021 forecasts on Thursday to include sales from its Alexio...
Read more29 Jul 2021 07:10
AstraZeneca COVID vaccine sales jump to $894 mln, updates forecasts
July 29 (Reuters) - AstraZeneca's COVID-19 vaccine sales more than tripled to $894 million in the second quarter from the previous three months but shaved off 1 U.S. cent from earnings, and the drugmaker updated its 2021 forecasts on Thursday to ...
Read more29 Jul 2021 03:06
UPDATE 5-Australian military to help enforce Sydney COVID-19 lockdown as cases rise
* Sydney records 239 COVID-19 cases in 24 hours* 300 military personnel to aid police* Troops to aid enforcement of lockdown* Sydney lockdown threatens second recession (Adds details of Australian military personnel helping enforce lockdown of Sydn...
Read more28 Jul 2021 16:35
UK sends first of 100 million promised vaccine doses to poorer nations
UK sends first of 100 million promised vaccine doses to poorer nations
Read more28 Jul 2021 14:51
Hutchmed research costs deepen loss; expects US launches in 2022, 2023
Hutchmed research costs deepen loss; expects US launches in 2022, 2023
Read more28 Jul 2021 12:20
UPDATE 2-Raab calls for global vaccine drive as UK starts donating shots
(Adds Raab interview, adds media identifier COVAX)By Andrew MacAskillOXFORD, England, July 28 (Reuters) - British Foreign Secretary Dominic Raab warned that the world would not be adequately vaccinated until 2024 unless other countries joined Brit...
Read more28 Jul 2021 12:20
UPDATE 1-UK starts donating 9 million COVID-19 vaccines overseas
(Adds details, Foreign Secretary quote)LONDON, July 28 (Reuters) - Britain will start delivering 9 million doses of Oxford-AstraZeneca COVID-19 vaccine this week to countries including Indonesia, Jamaica and Kenya to help tackle the pandemic, the ...
Read more28 Jul 2021 11:33
IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial
IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial
Read more28 Jul 2021 10:58
AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%
AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%
Read more28 Jul 2021 07:53
UPDATE 2-AstraZeneca finds small clot risk after 1st COVID shot, less after 2nd
* Study finds TTS rate 8.1 per million after 1st dose* Study finds TTS rate 2.3 per million after 2nd dose* Results back 2nd dose, unless TTS after 1st - company (Writes through with detail)By Pushkala AripakaJuly 28 (Reuters) - AstraZeneca's COVID-...
Read more27 Jul 2021 15:19
IMF calls for rapid action to increase access to Covid-19 vaccines
(Sharecast News) - The International Monetary Fund's chief economist called on world governments to improve low-and-middle income countries' access to vaccines in order to avoid downside risks.
Read more27 Jul 2021 12:56
AstraZeneca partners with Regeneron to research obesity treatment
AstraZeneca partners with Regeneron to research obesity treatment
Read more